secwatch.observer — SEC 8-K summary
======================================

Issuer:     Phathom Pharmaceuticals, Inc. (PHAT)
CIK:        0001783183
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001193125-23-156713
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Phathom shareholders approve officer liability amendment, elect directors, ratify auditor; board updates director comp
--------------------------------------------------------------------------------

- Shareholders approved amendment eliminating personal liability of officers for monetary damages for breach of fiduciary duty (effective May 26, 2023).
- Terrie Curran and Mark Stenhouse elected as Class I directors for three-year terms; votes for: Curran 32.2M, Stenhouse 29.0M.
- Ernst & Young ratified as independent auditor for 2023 with 38.9M votes for (99.9%).
- Board updated non-employee director compensation: new directors get 18K RSUs + options for 30K shares; annual grants of 9K RSUs + options for 15K shares.
- Proposal to limit officer liability passed with 30.1M votes for, 2.1M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783183/000119312523156713/0001193125-23-156713-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783183/000119312523156713/d487635d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-156713

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer